Wintest
6721
Osaka Yuka Industry
4124
D. Western Therapeutics Institute
4576
Asiro
7378
Hamee
3134
(FY)May 31, 2024 | (FY)May 31, 2023 | (FY)May 31, 2022 | (FY)May 31, 2021 | (FY)May 31, 2020 | (FY)May 31, 2019 | (FY)May 31, 2018 | (FY)May 31, 2017 | (FY)May 31, 2016 | (FY)May 31, 2015 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating cash flow (Indirect Method) | ||||||||||
Cash from operating activities | 177.18%8.56B | 124.49%3.09B | -73.20%1.38B | -24.66%5.13B | 4.30%6.81B | 55.51%6.53B | 58.65%4.2B | 3.28%2.65B | -47.29%2.56B | -4.65%4.86B |
Net profit before non-cash adjustment | 89.72%2.75B | -3.46%1.45B | -23.57%1.5B | 18.67%1.96B | -25.18%1.66B | -11.77%2.21B | 111.56%2.51B | -50.58%1.19B | -30.67%2.4B | -6.39%3.46B |
Total adjustment of non-cash items | 0.77%2.75B | 79.21%2.73B | -18.14%1.53B | 0.49%1.86B | -38.30%1.85B | 106.81%3.01B | -27.02%1.45B | -25.49%1.99B | -0.78%2.67B | 92.22%2.69B |
-Depreciation and amortization | 1.26%2.26B | 16.40%2.23B | -3.23%1.92B | -2.51%1.98B | 14.75%2.03B | 2.55%1.77B | 6.48%1.73B | -14.42%1.62B | 4.13%1.89B | 17.14%1.82B |
-Reversal of impairment losses recognized in profit and loss | -75.44%84M | --342M | --0 | 4,600.00%329M | -98.67%7M | 2,535.00%527M | --20M | ---- | 37.92%371M | --269M |
-Assets reserve and write-off | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 600.00%63M | 112.00%9M |
-Share of associates | 1,350.00%261M | 228.57%18M | -106.93%-14M | -3.35%202M | 574.19%209M | 186.11%31M | 60.44%-36M | 53.09%-91M | 10.19%-194M | 30.32%-216M |
-Disposal profit | 78.80%-46M | 60.55%-217M | 49.22%-550M | -218.53%-1.08B | -258.14%-340M | 132.48%215M | -1,279.17%-662M | -142.48%-48M | 665.00%113M | -121.74%-20M |
-Pension and employee benefit expenses | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 175.76%75M | 34.00%-99M |
-Other non-cash items | -45.15%198M | 107.47%361M | -60.09%174M | 938.46%436M | -111.23%-52M | 14.04%463M | -20.39%406M | 45.30%510M | -62.34%351M | 219.18%932M |
Changes in working capital | 379.18%3.06B | 33.52%-1.1B | -226.21%-1.65B | -60.45%1.31B | 151.91%3.3B | 450.42%1.31B | 145.08%238M | 78.93%-528M | -94.57%-2.51B | -25,860.00%-1.29B |
-Change in receivables | 118.33%396M | -484.34%-2.16B | -67.06%562M | -31.68%1.71B | 422.61%2.5B | -301.04%-774M | 43.73%-193M | -133.93%-343M | 247.16%1.01B | 54.92%-687M |
-Change in inventory | 45.73%290M | 110.10%199M | -187.52%-1.97B | 325.71%2.25B | -50.84%529M | 578.22%1.08B | 81.85%-225M | -21.57%-1.24B | -280.53%-1.02B | 128.29%565M |
-Change in payables | 20.52%1.11B | 386.02%921M | 87.49%-322M | -176.37%-2.57B | -572.59%-931M | -34.77%197M | -67.42%302M | 151.73%927M | -204.76%-1.79B | -119.59%-588M |
-Provision for loans, leases and other losses | 728.35%798M | -204.10%-127M | 1,455.56%122M | -128.13%-9M | 120.78%32M | -125.97%-154M | 5,490.91%593M | ---11M | ---- | ---- |
-Changes in other current assets | 102.69%13M | -1,565.52%-483M | 92.79%-29M | -135.08%-402M | 234.11%1.15B | 229.81%343M | -25.18%104M | 768.75%139M | 105.54%16M | -775.76%-289M |
-Changes in other current liabilities | -18.92%450M | 6,266.67%555M | -102.72%-9M | 1,125.93%331M | -95.66%27M | 281.34%622M | ---343M | ---- | -149.48%-721M | -151.89%-289M |
Dividends paid (cash flow from operating activities) | ||||||||||
Dividends received (cash flow from operating activities) | ||||||||||
Interest paid (cash flow from operating activities) | 39.72%-261M | -101.40%-433M | 5.29%-215M | 17.45%-227M | 13.25%-275M | -16.12%-317M | -14.71%-273M | 0.83%-238M | -2.56%-240M | 4.10%-234M |
Interest received (cash flow from operating activities) | 5.41%156M | 0.68%148M | -0.68%147M | -23.71%148M | -26.79%194M | 10.88%265M | 18.32%239M | 9.78%202M | 12.88%184M | 6.54%163M |
Tax refund paid | -3.50%-1.04B | -7.29%-1B | -5.19%-933M | -6.61%-887M | 29.97%-832M | -83.62%-1.19B | 60.26%-647M | -54.31%-1.63B | 3.30%-1.06B | -105.08%-1.09B |
Other operating cash inflow (outflow) | 29M | 0 | 0 | -1M | 0 | -53,200.00%-533M | 0.00%-1M | -1M | 0 | -200.00%-1M |
Operating cash flow | 313.20%7.45B | 380.80%1.8B | -91.00%375M | -29.38%4.17B | 23.97%5.9B | 35.27%4.76B | 257.99%3.52B | -32.35%983M | -60.74%1.45B | -17.37%3.7B |
Investing cash flow | ||||||||||
Net PPE purchase and sale | 51.97%-1.28B | -86.49%-2.67B | 35.16%-1.43B | -51.79%-2.2B | -34.94%-1.45B | -14.23%-1.08B | 64.05%-942M | -256.46%-2.62B | 43.89%-735M | -37.75%-1.31B |
Net intangibles purchase and sale | -203.03%-300M | 61.02%-99M | -20.38%-254M | 51.38%-211M | 15.07%-434M | -131.22%-511M | -784.00%-221M | 71.59%-25M | -49.15%-88M | -18.00%-59M |
Net business purchase and sale | -158.22%-1.1B | -425.93%-426M | -135.37%-81M | 615.63%229M | --32M | ---- | --16M | ---- | ---- | ---- |
Net investment product transactions | 0.00%355M | -38.47%355M | -63.34%577M | 394.97%1.57B | 127.14%318M | -84.50%140M | 90.51%903M | 119.82%474M | -16,978.57%-2.39B | -16.67%-14M |
Advance cash and loans provided to other parties | --0 | 75.00%-1M | 42.86%-4M | -250.00%-7M | 0.00%-2M | 50.00%-2M | -300.00%-4M | 75.00%-1M | 33.33%-4M | -100.00%-6M |
Repayment of advance payments to other parties and cash income from loans | -25.00%3M | -20.00%4M | 66.67%5M | 50.00%3M | 0.00%2M | -33.33%2M | 0.00%3M | -40.00%3M | -16.67%5M | 0.00%6M |
Net changes in other investments | 50.00%-1M | 60.00%-2M | 96.38%-5M | ---138M | ---- | -200.00%-1M | 200.00%1M | -150.00%-1M | -98.68%2M | 172.04%152M |
Investing cash flow | 18.03%-2.32B | -137.95%-2.83B | -57.96%-1.19B | 50.91%-754M | -6.08%-1.54B | -493.44%-1.45B | 88.76%-244M | 32.42%-2.17B | -160.84%-3.21B | -0.82%-1.23B |
Financing cash flow | ||||||||||
Net issuance payments of debt | -321.08%-3.39B | 318.23%1.53B | 64.51%-702M | -215.34%-1.98B | 246.33%1.72B | -243.98%-1.17B | -59.50%814M | 12.35%2.01B | 266.26%1.79B | -642.07%-1.08B |
Net common stock issuance | --781M | --0 | --0 | 101.12%18M | 22.21%-1.6B | -102,800.00%-2.06B | -100.00%-2M | 0.00%-1M | 50.00%-1M | -100.00%-2M |
Increase or decrease of lease financing | -1.35%-750M | -8.03%-740M | 10.92%-685M | 14.08%-769M | -48.92%-895M | 3.84%-601M | 17.11%-625M | 16.59%-754M | -2.15%-904M | -9.12%-885M |
Cash dividends paid | 18.88%-361M | -27.87%-445M | -83.16%-348M | 59.40%-190M | 8.41%-468M | 3.04%-511M | 0.00%-527M | -7.55%-527M | 0.20%-490M | -30.24%-491M |
Cash dividends for minorities | -23.12%-490M | -18.10%-398M | -33.20%-337M | 43.90%-253M | 27.26%-451M | -11.71%-620M | -49.60%-555M | ---371M | ---- | ---- |
Net other fund-raising expenses | 400.00%3M | 50.00%-1M | 0.00%-2M | 0.00%-2M | 0.00%-2M | -103.85%-2M | 1,833.33%52M | 98.91%-3M | 8.94%-275M | -168.79%-302M |
Financing cash flow | -7,984.62%-4.2B | 97.49%-52M | 34.66%-2.07B | -86.49%-3.17B | 65.71%-1.7B | -488.85%-4.96B | -338.14%-843M | 197.48%354M | 104.32%119M | -207.93%-2.76B |
Net cash flow | ||||||||||
Beginning cash position | -13.06%6.93B | -25.90%7.97B | 4.34%10.76B | 32.95%10.31B | -17.61%7.75B | 35.80%9.41B | -11.27%6.93B | -18.16%7.81B | -0.22%9.54B | 33.15%9.56B |
Current changes in cash | 185.23%923M | 62.53%-1.08B | -1,309.21%-2.89B | -91.03%239M | 261.20%2.66B | -167.93%-1.65B | 391.96%2.43B | 49.18%-833M | -473.08%-1.64B | -112.10%-286M |
Effect of exchange rate changes | 614.29%300M | -59.62%42M | -50.00%104M | 290.83%208M | -3,533.33%-109M | -106.00%-3M | 204.17%50M | 48.94%-48M | -148.70%-94M | 915.79%193M |
Cash adjustments other than cash changes | --1M | ---- | ---- | ---- | 150.00%1M | -100.00%-2M | -200.00%-1M | --1M | ---- | 7,300.00%72M |
End cash Position | 17.66%8.15B | -13.06%6.93B | -25.90%7.97B | 4.34%10.76B | 32.95%10.31B | -17.61%7.75B | 35.80%9.41B | -11.27%6.93B | -18.16%7.81B | -0.22%9.54B |
Free cash flow | 406.24%3.78B | 69.46%-1.23B | -356.25%-4.04B | -59.89%1.58B | 25.06%3.93B | 33.90%3.14B | 235.10%2.35B | -378.97%-1.74B | -71.94%623M | -24.15%2.22B |
Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |